MedTrace Logo

A Comparison of Laboratory Versus Point of Care (Bedside) APTT Testing

NCT04744701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2021-02-09

No results posted yet for this study

Summary

The overall aim of the study is to determine whether point-of-care (bedside) Activated Partial Thromboplastin Time (APTT) testing would be better than laboratory APTT testing in the PICU population (restricted to children under 16 years of age).

Conditions

  • Critical Care
  • Child

Interventions

DIAGNOSTIC_TEST

Hemochron Signature Elite Whole Blood Microcoagulation System

Bedside test of Activated Partial Thromboplastin Time

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Tim Lee, MD, PhD · University of Leeds

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-10
Primary Completion
2020-04-01
Completion
2020-04-01
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04744701 on ClinicalTrials.gov